• Users Online: 345
  • Print this page
  • Email this page
CASE REPORT
Year : 2022  |  Volume : 8  |  Issue : 2  |  Page : 116-119

Repurposed oral tapentadol as an intravenous drug of abuse in opioid dependence


Department of Psychiatry, Deccan College of Medical Sciences, Hyderabad, Telangana, India

Correspondence Address:
Dr. Mazher Ali
Department of Psychiatry, Deccan College of Medical Sciences, DMRL X Road, Santosh Nagar Main Road, Kanchan Bagh, Hyderabad - 500 058, Telangana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/tjp.tjp_48_22

Rights and Permissions

We present to you a case series of a group of individuals who presented to us with a history of intravenous drug abuse of repurposed oral tapentadol. Tapentadol is a synthetic benzenoid with a dual mode of action, as an agonist for the μ-opioid receptor and a norepinephrine reuptake inhibitor, with potential anti-nociceptive activity. The prevalence of current opioid use in India is reported to be 4% in males and 0.2% in females. Limited availability and difficulty in procuring the recommended drugs for detoxification and maintenance therapy in opioid dependence give reasons to consider treatment alternatives for the same. This case series aims to address the need and effectiveness of evidence-based treatment in opioid dependence.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed220    
    Printed38    
    Emailed0    
    PDF Downloaded18    
    Comments [Add]    

Recommend this journal